Fetal development is a critical period for shaping the lifelong health of an individual.
However, the fetus is susceptible to internal and external stimuli that can lead to adverse …

The early environment has a major impact on the developing embryo, fetus, and infant.
Parental adversity (maternal and paternal) and glucocorticoid exposure before conception …

Rheumatic diseases in women of childbearing years may necessitate drug treatment during
a pregnancy, to control maternal disease activity and to ensure a successful pregnancy …

Antenatal corticosteroids are standard of care for pregnancies at risk of preterm delivery
between 24-34 weeks' gestational age. Recent trials demonstrate modest benefits from …

SUMMARY 1 Intrauterine growth restriction (IUGR) has been associated with poor perinatal
health outcomes. Animal models have been used to investigate why IUGR is associated with …

Studies of cervical sonography, fetal fibronectin, and uterine contraction monitoring during
pregnancy have improved our understanding of how preterm labor occurs, but their use in …

Background We previously reported the results of a randomized, controlled trial showing that
repeat doses of antenatal corticosteroids reduced the risk of respiratory distress syndrome …

Cancer in pregnancy presents a rare coincidence which demands intensive interdisciplinary
care. Among this, gynecologic cancer is a special challenge because cancer or treatment …

Fetal growth restriction (FGR) is etiologically associated with various maternal, fetal and
placental factors, although such an association may not be present in many cases. Maternal …

Objectives To determine if antenatal exposure to betamethasone for the prevention of
neonatal respiratory distress syndrome alters psychological functioning and health related …